MedTrace Logo

Study of PM Modulation Therapy in Trial Phase

NCT03110601 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2019-04-16

Study results available
· View outcomes & findings →

Summary

Trialing of PM modulation therapy in patients with chronic intractable low back pain

Conditions

Interventions

DEVICE

Control - Conventional SCS

Conventional SCS Parameters

DEVICE

Test - Stimgenics SCS

Stimgenics SCS Parameters

Sponsors & Collaborators

  • Stimgenics LLC

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-05
Primary Completion
2017-10-12
Completion
2017-10-12
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03110601 on ClinicalTrials.gov